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Abstract
Background and Purpose:  The impact of traumatic brain injury (TBI) on the pathogenesis of
Alzheimer disease (AD) is still controversial. The aim of our retrospective autopsy study was to
assess the impact of TBE and ApoE allele frequency on the development of AD.
Material and Methods:  We examined 1. the incidence of AD pathology (Braak stageing,
CERAD, NIA-Reagan Institute criteria) in 58 consecutive patients (mean age ± SD 77.0 ± 6.8 years)
with residual closed TBI lesions, and 2. the frequency of TBI residuals in 57 age-matched autopsy
proven AD cases. In both series, ApoE was evaluated from archival paraffin-embedded brain
material.
Results:  1. TBE series: 12.1 % showed definite and 10.3% probable AD (mean age 77.6 and 75.2
years), only 2/13 with ApoEε 3/4. From 45 (77.6%) non-AD cases (mean age 78.2 years), 3 had
ApoEε 3/4. The prevalence of 22.4% AD in this small autopsy cohort was significantly higher than
3.3% in a recent large clinical series and 14% in the general population over age 70. 2. In the AD
cohort with ApoEε 4 allele frequency of 30% similar to other AD series, residuals of closed TBI
were seen in 4 brains (7%) (mean age ± SD 78.2 ± 6.4), all lacking the ApoEε 4 allele. TBI incidence
was slightly lower than 8.5% in the clinical MIRAGE study.
Conclusions:  The results of this first retrospective autopsy study of TBI, ApoEε  allele frequency,
and AD confirm clinical studies suggesting severe TBI to be a risk factor for the development AD
higher in subjects lacking ApoEε 4 alleles. Further studies in larger autopsy series are needed to
elucidate the relationship between TBI, genetic predisposition, and AD.
Introduction
While some genetic risk factors, e.g. apolipoprotein
(ApoE)ε 4, predispose the elderly to develop Alzheimer
disease (AD), the role of traumatic brain injury (TBI) in
the pathogenesis of AD is still controversial. Accumulat-
ing epidemiological evidence implicates TBI as a risk fac-
tor for the subsequent development of AD [for rev. see
[1,2], while others reported no such association [see
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[3,4]. In the MIRAGE study, head injury as a risk factor
for AD appeared greater among subjects lacking ApoEε 4
[5]. Among longitudinal studies [6–9], two reported a
significantly increased riks of developing AD in subjects
with previous history of TBI [8,9] A recent study of 1776
US World War II navy veterans showed that moderate
and severe TBI in early adulthood, rated by the duration
of loss of consciousness or posttraumatic amnesia, was
associated with increased risk of AD and dementia in late
life (assessed by clinical protocols). The risk increased
with the severity of the TBI and showed a nonsignificant
trend towards a stronger association between AD and
TBI in men with ApoEε 4 alleles [9]. Although it is well
established that deposition of amyloid β  peptide (Aβ )
known to play an important role in the pathogenesis of
AD, in fatal TBI is associated with an ApoEε 4 allele
[10,11] and that TBI may induce tau pathology with the
formation of neurofibrillary tangles, another major his-
tological marker of AD [12,13], the mechanisms by which
TBI may induce the formation of AD pathology are still
unknown, and several interpretations have been pro-
posed [13,14]. Whereas previous case-control and longi-
tudinal epidemiological studies on the association
between TBI and AD were exclusively based on clinical
protocols, we present here data of a retrospective autop-
sy study on the relations between TBI residual lesions,
ApoE allele frequency, and AD pathology.
Material and Methods
We examined two autopsy series from the research files
of the Ludwig Boltzmann Institute of Clinical Neurobiol-
ogy brain bank, Vienna, Austria, between 1977 and 2000.
This material was mainly derived from a large teaching
hospital with associated chronic hospital (together
around 3000 beds) in Vienna, Austria. In this retrospec-
tive study, exact informations about IQ, education, and
other major risk factors for AD were not available. 1. In a
consecutive series of 58 patients over age 60 (mean ± SD
77.0 ± 6.8) years with residual closed TBI pathology we
looked for the incidence of AD pathology. 2. In a consec-
utive series of 57 age-matched autopsy proven AD cases
(mean ± SD age 77.6 ± 7.3 years) we looked for the pres-
ence of morphological TBI residuals. All patients were
Caucasians and immunocompetent. All brains were ex-
amined histologically using routine stains including
modified Bielschowsky silver stain and immunohisto-
chemistry with a battery of antibodies against ABl-42,
PHF tau (antibody AT-8), ubiquitin, and α -synuclein for
the demonstration of Lewy bodies. The classification of
AD was performed according to the Khachaturian crite-
ria [15], the Consortium to Establish a Registry for Alzhe-
imer Disease (CERAD) criteria [16], the Braak stageing
of neuritic Alzheimer lesions [17], and the National Insti-
tute on Aging (NIA)-Reagan Institute classification for
the postmortem diagnosis of AD [18]. Evaluation of
ApoE alleles was performed in all cases of both cohorts
from archival paraffin-embedded brain material using a
semi-nested PCR method [19]. Since ApoE genotyping
was performed retrospectively in cohort 1, no controls
for older, non-TBI subjects were available. Statistical
evaluation was performed using Chi-square test and the
Mann-Whitney U-test.
Results
1. TBE series
Among the 58 autopsy cases over age 60 with residuals
of closed TBI of various degrees and distribution, 7
brains or 12.1% (4 males and 3 females aged 69 to 83,
mean ± SD 77.6 ± 6.4 years, revealed the pathological fea-
tures of definite AD, i.e. Khachaturian positive, CERAD
B or C, Braak stages 5 or 6, with a great likelihood of AD
as cause of dementia according to the NIA-Reagan crite-
ria. Only one of them exhibited ApoEε 4, all the others
were ε 3/3 and ε 2/3 (3 each). All these brains, in addition
to severe neuritic AD pathology showed posttraumatic
lesions of limited extent and various distribution, mainly
old contusions in bilateral frontobasal areas (n = 1), fron-
totemporal (n = 1), right frontobasal and temporal(n = 2)
with additional old cerebellar contusion (n = 2), and
right frontal pole (n = 1). TBI history dated back 10 to 30
years prior to the death, but was unknown in 2 of these
patients. The duration of AD ranged from 4 to 7 years.
Two additional AD cases – 2 males aged 69 and 82 years,
respectively – were excluded since the TBI due to falls
had occurred 2 to 4 months prior to death after the devel-
opment of severe dementia. Both brains showed definite
AD (CERAD C, Braak stage 5); both were ApoE ε 2/3.
Further 6 cases or 10.3% (3 men and women each, aged
65-85, mean ± SD 75.2 ± 6.4 years) were pathologically
classified "probable" AD, meeting positive Khachaturian
criteria, CERAD B, Braak 3 or 4; with intermediate like-
lihood of AD as cause of dementia according to the NIA-
Reagan criteria; only one of them had ApoEε 3/4 allele,
the others ε 3/3 or ε 2/3. In these patients, closed TBI had
occurred between 8 and 39 years prior to death and
many years before development of cognitive impair-
ment, the duration of which ranged from 3 to 7 years.
Neuropathology, in addition to AD lesions, revealed bi-
lateral old traumatic contusional deficits or scars in
frontobasal and temporopolar areas (n = 2), in the right
frontopolar and temporal, and in the left frontobasal and
temporal or in the left parietal region (2 cases each).
None of these subjects had a history of chronic alcohol-
ism, Korsakoff syndrome or any morphological signs of
Wernicke encephalopathy or essential concomitant cere-
brovascular lesions except for occasional mild lacunar
state in the basal ganglia. None of them meet the mor-
phological criteria for mixed type dementia (combina-
tion of AD and vascular encephalopathy), of Parkinson
disease (PD) or of dementia with Lewy bodies (DLB) [20].BMC Neurology (2001) 1:3 http://www.biomedcentral.com/1471-2377/1/3
In the remaining 45 non-AD cases (77.6%; 36 men and 9
women aged 61 to 85, mean ± SD 78.2 ± 7.8 years), the
ApoE allele frequency was ε 3/3 (n = 39), ε 3/4 and ε 2/3
(n = 3 each) comparable to that in the general aged pop-
ulation [21–23]. Old traumatic brain lesions in this co-
hort were seen mainly in the frontobasal, frontopolar
and temporopolar areas, less frequently frontobasal and
frontopolar or temporal/ temporopolar unilaterally or
bilaterally. In two of these cases (aged 85 and 86 years),
neuropathology revealed additional PD of the Lewy body
type with no only very few cortical Lewy bodies, thus ex-
cluding DLB [20].
2. AD cohort
Among 57 consecutive autopsy cases of definite AD aged
71 to 91 years with a mean ± SD of 77.6 ± 7.3 years the
ApoeEε 4 allele frequency was 30% (ε 4/4 n = 6; ε 3/4 n =
11) which was comparable to that in other AD series
ranging from 24 to 38% [21–25]; all the others were ε 3/
3 or 2/3. Residuals of closed TBI were seen in 4 brains or
7.0 %, 2 men and women each aged 71-91 (mean ± SD
78.2 ± 5.6) years, all lacking ApoeEε 4 alleles. They had
suffered closed head injuries 7 to 54 years prior to death
and, like in cohort 1, many years before onset of cognitive
deterioration. A male dying at age 71 years has suffered a
blow to the right parietal region with several hours un-
consciousness 54 years prior to death; two women aged
76 and 91 years had suffered TBI with unknown duration
of unconsciousness in car accidents 7 and 30 years before
death, and a male aged 75 years had TBI with short un-
consciousness due to a fall on the occiput 8 years prior to
death, and a duration of AD of about 2 years. None of
them had experienced repeated TBI as boxers or other
sportsmen. Neuropathology, in addition to definite AD
changes (Khachaturian positive, CERAD stage B or C,
Braak stages 4 or 5, i.e. intermediate or high likelihood of
AD as the cause of dementia according to the NIA-Rea-
gan criteria), revealed old contusional scars in the
frontobasal and temporal areas (n = 3) and in the pari-
etal region (n = 1).
Discussion
To the best of our knowledge, this is the first study to de-
tect AD pathology in a consecutive autopsy series of post-
traumatic brain lesions and to look for the presence of
residual brain lesions of closed TBI in a cohort of autopsy
proven AD cases. The prevalence of 22.3% of probable
and definite AD in a rather small cohort of subjects with
a mean age of 75 to 77.6 years and residuals of closed TBI
is considerably higher (p < 0.001) than 3.3% in the re-
cent clinical US series of VA subjects who sustained mod-
erate to severe TBI during World War II [9]. It was also
higher than the prevalence of AD in the general Cauca-
sian population showing a wide range between 3 and 11%
for those older than 65 years (p < 0.001), about 14% for
those older than 70, and between 7 and 50% for subjects
older than 85 years [26–31]. In comparison to AD pa-
tients showing an ApoEε 4 prevalence of 24 to 38% [21–
25], it was only 15.4% in the present cohort of AD cases
with residual TBI lesions. The extent and distribution did
not seem to influence later developrent of AD. Since in
the majority of the patients later developing AD, TBI his-
tory 10 to 30 years prior to death and the mean age of
these patients was comparable to the non-AD cases, one
might exclude the possibility that a greater injury may
have a bigger effect on AD development, especially when
interacting with older age which is the most significant
factor in AD [see [1]]. Since in this retrospective study no
exact information on pre-morbid intellectual levels and
education were available, no suggestions about brain re-
serve capacity (BRC) as a potential moderating factor on
risk variables related to AD expression can be made.
The prevalence of residuals of previous closed TBI in 7%
of a consecutive series of autopsy-proven AD aged 71 to
91 (mean 77.6 ± 7.3) years, all lacking an ApoEε 4 allele,
was slightly lower than in the large clinical MIRAGE
study, where TBI with loss of consciousness in AD
probands was reported in 8.5% [5]. This study like ours
indicates that closed head injury is a higher risk factor for
the development of AD among subjects lacking ApoEε 4
alleles compared to those having them. This is in accord-
ance with recent experimental data showing that trans-
genic mice expressing human ApoEε 4 are more
susceptible than those expressing ApoEε 3 to closed head
injury, probably related to a protective effect of ApoEε 3
and an ApoEε 4-related pathological function [32].
In conclusion, the results of this first retrospective study
on the association of TBI and ApoE allele frequency on
the development of AD confirm clinical studies suggest-
ing some influence of severe TBI on the development of
AD, being a higher risk factor for AD among subjects
lacking ApoEε 4 alleles compared to those having them.
However, further studies in larger autopsy series of TBI
and AD are needed to further elucidate the relationshipt
between closed TBI, ApoE allele, and the development of
AD.
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